Literature DB >> 27853629

Current progress of human trials using stem cell therapy as a treatment for diabetes mellitus.

Shuk Kei Cheng1, Elisse Y Park1, Andjela Pehar1, Alexandra C Rooney1, G Ian Gallicano2.   

Abstract

Diabetes mellitus affects millions of people worldwide, and is associated with serious complications that affect nearly all body systems. Because of the severity of this global health concern, there is a great deal of research being performed on alternative treatments and possible cures. Previous treatments for diabetes have included exogenous insulin injection and pancreatic islet transplantations. These treatment methods have several limitations; thus, the use of stem cells in treating diabetes is currently a significant area of research. This review outlines current research on stem cell therapy for diabetes mellitus. Numerous studies have been performed on animals using various types of stem cells, including mesenchymal stem cells and embryonic stem cells. Moreover, results and limitations of animal studies have been confirmed in various clinical trials. Overall, stem cell treatment shows prospective advantages over insulin injections and other current treatment options, and ongoing clinical trials suggest that this therapy may be a viable treatment option for diabetics in the near future.

Entities:  

Keywords:  Diabetes; IPS cells; adult stem cells; embryonic stem cells; human trials; spermatogonial stem cells

Year:  2016        PMID: 27853629      PMCID: PMC5107652     

Source DB:  PubMed          Journal:  Am J Stem Cells        ISSN: 2160-4150


  48 in total

Review 1.  Mesenchymal stem cells as trophic mediators.

Authors:  Arnold I Caplan; James E Dennis
Journal:  J Cell Biochem       Date:  2006-08-01       Impact factor: 4.429

Review 2.  Generation of β cells from human pluripotent stem cells: are we there yet?

Authors:  Jacqueline V Schiesser; James M Wells
Journal:  Ann N Y Acad Sci       Date:  2014-02-24       Impact factor: 5.691

3.  Pancreatic islet transplantation.

Authors:  Hirofumi Noguchi
Journal:  World J Gastrointest Surg       Date:  2009-11-30

4.  Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep.

Authors:  T C Mackenzie; A W Flake
Journal:  Blood Cells Mol Dis       Date:  2001 May-Jun       Impact factor: 3.039

Review 5.  Stem cells and diabetes treatment.

Authors:  Ole Dragsbaek Madsen
Journal:  APMIS       Date:  2005 Nov-Dec       Impact factor: 3.205

Review 6.  Treatment of new onset type 1 diabetes with teplizumab: successes and pitfalls in development.

Authors:  Nalini K Vudattu; Kevan C Herold
Journal:  Expert Opin Biol Ther       Date:  2014-03       Impact factor: 4.388

7.  Induction of pancreatic β cell gene expression in mesenchymal stem cells.

Authors:  Zahra Mehrfarjam; Fariba Esmaeili; Leila Shabani; Esmaeil Ebrahimie
Journal:  Cell Biol Int       Date:  2016-03-21       Impact factor: 3.612

8.  Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus.

Authors:  Esteban J Estrada; Fabian Valacchi; Eduardo Nicora; Sergio Brieva; Claudio Esteve; Laura Echevarria; Tatiana Froud; Karina Bernetti; Shari Messinger Cayetano; Omaida Velazquez; Rodolfo Alejandro; Camillo Ricordi
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

9.  Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1.

Authors:  Guiting Lin; Guifang Wang; Gang Liu; Li-Jun Yang; Lung-Ji Chang; Tom F Lue; Ching-Shwun Lin
Journal:  Stem Cells Dev       Date:  2009-12       Impact factor: 3.272

10.  Acute response of peripheral blood cell to autologous hematopoietic stem cell transplantation in type 1 diabetic patient.

Authors:  Xiaofang Zhang; Lei Ye; Jiong Hu; Wei Tang; Ruixin Liu; Minglan Yang; Jie Hong; Weiqing Wang; Guang Ning; Weiqiong Gu
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

View more
  2 in total

1.  The combined effect of Pdx1 overexpression and Shh manipulation on the function of insulin-producing cells derived from adipose-tissue stem cells.

Authors:  Mahmoud Hashemi Tabar; Mohammad Reza Tabandeh; Eskandar Moghimipour; Dian Dayer; Ata A Ghadiri; Elham Allah Bakhshi; Mahmoud Orazizadeh; Mohammad Ali Ghafari
Journal:  FEBS Open Bio       Date:  2018-02-05       Impact factor: 2.693

Review 2.  Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD).

Authors:  Mark Fields; Hui Cai; Jie Gong; Lucian Del Priore
Journal:  Cells       Date:  2016-12-08       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.